ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TMDX Company Profile and Key Details

NASDAQ : TMDX

TransMedics Group, Inc.

$89.88

-2.55-2.76%

Open: 10:39 AM

58.36

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

TransMedics Group, Inc. (TMDX) stock declined over -2.76%, trading at $89.88 on NASDAQ, down from the previous close of $92.43. The stock opened at $89.43, fluctuating between $89.01 and $91.23 in the recent session.

Stock Snapshot

92.43

Prev. Close

3.04B

Market Cap

89.01

Day Low

P/E Ratio

1.07

EPS (TTM)

-5.62

Cash Flow per Share

89.43

Open

33.82M

Number of Shares

91.23

Day High

96.19%

Free Float in %

4.01

Book Value

210.3K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 29, 2025	91.14	92.48	89.05	92.43	790.23K
Apr 28, 2025	93.90	95.71	88.50	90.19	1.13M
Apr 25, 2025	93.19	93.85	89.65	93.50	1.3M
Apr 24, 2025	92.50	95.16	91.70	94.18	974.57K
Apr 23, 2025	95.00	95.90	91.39	92.25	1.17M
Apr 22, 2025	88.58	92.01	88.00	91.21	1.16M
Apr 21, 2025	87.85	89.33	86.14	87.72	884.15K
Apr 17, 2025	85.32	88.39	84.53	88.24	967.79K
Apr 16, 2025	86.26	86.79	82.62	85.38	1.25M
Apr 15, 2025	86.21	87.27	83.25	87.18	1.25M
Apr 14, 2025	82.57	88.48	81.92	86.84	1.6M
Apr 11, 2025	76.12	81.26	75.50	80.58	1.04M
Apr 10, 2025	73.83	78.71	72.78	76.37	1.58M
Apr 09, 2025	67.26	77.21	66.85	75.41	2.12M
Apr 08, 2025	72.87	73.07	67.18	67.95	1.13M
Apr 07, 2025	64.29	71.94	62.23	69.15	1.64M
Apr 04, 2025	68.32	69.00	64.55	67.67	1.37M
Apr 03, 2025	69.00	71.72	68.00	70.96	1.12M
Apr 02, 2025	67.18	73.59	66.82	73.11	1.12M
Apr 01, 2025	66.33	69.69	66.23	68.27	631.23K

Contact Details

Andover, MA 01810

United States

https://www.transmedics.com 978 552 0900

About Company

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 PODD

-8.25-3.18%

Insulet Corporation$251.27 UFPT

1.8+0.86%

UFP Technologies, Inc.$211.60 ALGN

-3.34-1.84%

Align Technology, Inc.$177.75 IRTC

iRhythm Technologies, Inc.$106.64 NARI

Inari Medical, Inc.$79.97 DXCM

0.12+0.17%

DexCom, Inc.$71.30 AXNX

Axonics, Inc.$70.98 PRCT

2.15+3.97%

PROCEPT BioRobotics Corporation$56.31 IRMD

0.68+1.28%

IRadimed Corporation$53.70

Frequently Asked Questions

What is the current TransMedics Group, Inc. (TMDX) stock price?

TransMedics Group, Inc. (NASDAQ: TMDX) stock price is $89.88 in the last trading session. During the trading session, TMDX stock reached the peak price of $91.23 while $89.01 was the lowest point it dropped to. The percentage change in TMDX stock occurred in the recent session was -2.76% while the dollar amount for the price change in TMDX stock was -$2.55.

TMDX's industry and sector of operation?

The NASDAQ listed TMDX is part of Medical - Devices industry that operates in the broader Healthcare sector. TransMedics Group, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TMDX?

Ms. Susan Goodman
Vice President of HR
Dr. Tamer I. Khayal M.D.
Chief Commercial Officer
Ms. Laura Damme
Vice President of Clinical Affairs
Dr. Waleed H. Hassanein M.D.
Founder, Pres, Chief Executive Officer & Director
Mr. Nick Corcoran
Senior Vice President of Supply Chain & Operations
Mr. Stephen Gordon
Chief Financial Officer, Treasurer & Sec.
Mr. Anil Ranganath
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Miriam C. Provost Ph.D.
Vice President of Global Regulatory Affairs
Mr. John F. Carey
Vice President of Operations

How TMDX did perform over past 52-week?

TMDX's closing price is 68.06% higher than its 52-week low of $55.00 where as its distance from 52-week high of $177.37 is -47.89%.

How many employees does TMDX have?

Number of TMDX employees currently stands at 728.

Link for TMDX official website?

Official Website of TMDX is: https://www.transmedics.com

How do I contact TMDX?

TMDX could be contacted at phone 978 552 0900 and can also be accessed through its website. TMDX operates from 200 Minuteman Road, Andover, MA 01810, United States.

How many shares of TMDX are traded daily?

TMDX stock volume for the day was 210.3K shares. The average number of TMDX shares traded daily for last 3 months was 1.2M.

What is the market cap of TMDX currently?

The market value of TMDX currently stands at $3.04B with its latest stock price at $89.88 and 33.82M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	728
Beta	2.13
Sales or Revenue	$241.62M
5Y Sales Change%	9.986%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices